BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 2274750)

  • 1. Renal effects of angiotensin II in the newborn period: role of type 1 and type 2 receptors.
    Vinturache AE; Smith FG
    BMC Physiol; 2016 Apr; 16():3. PubMed ID: 27090941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional role of sodium glucose transporter in high glucose-mediated angiotensin type 1 receptor downregulation in human proximal tubule cells.
    Yesudas R; Snyder R; Abbruscato T; Thekkumkara T
    Am J Physiol Renal Physiol; 2012 Sep; 303(5):F766-74. PubMed ID: 22647632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAS blockade: new possibilities in the treatment of complications of diabetes.
    Ruilope L
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i32-4:discussion i50. PubMed ID: 10956319
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal tubular responses to low-dose infusion of angiotensin II in type 1 diabetes mellitus; relation to chronic glycaemic control.
    Eadington DW; Frier BM; Swainson CP
    Nephrol Dial Transplant; 1994; 9(9):1264-70. PubMed ID: 7816287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
    Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus.
    Luik PT; Hoogenberg K; Van Der Kleij FG; Beusekamp BJ; Kerstens MN; De Jong PE; Dullaart RP; Navis GJ
    Diabetologia; 2002 Apr; 45(4):535-41. PubMed ID: 12032630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal sensitivity to angiotensin II in type 1 diabetes.
    Björck S; Aurell M; Bresäter LE; Herlitz H; Welin L; Wikstrand J
    Scand J Urol Nephrol; 1990; 24(4):267-73. PubMed ID: 2274750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
    Björck S
    Scand J Urol Nephrol Suppl; 1990; 126():1-51. PubMed ID: 2194280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts of renal hemodynamics in diabetes.
    Anderson S; Vora JP
    J Diabetes Complications; 1995; 9(4):304-7. PubMed ID: 8573753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and cardiovascular effects of atrial natriuretic factor.
    Maack T; Kleinert HD
    Biochem Pharmacol; 1986 Jul; 35(13):2057-64. PubMed ID: 3015142
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.